By isolating and characterizing osteosarcoma cell lines from FosTg and FosTg;Rsk2−/y mice, we observed that Rsk2 deficiency impairs the growth advantage of FosTg cells. This evidence concerns the gene RPS6KA3 and osteosarcoma.